Document Classification

Section Type: RESULTS

Text: The levels of EPCs were unaffected by ezetimibe 10/simvastatin 20 mg (median [25th, 75th] : pre - vs posttreatment, 7. 0 [2. 3 ; 13. 3] vs 3. 1 [0. 1 ; 13. 2] EPCs/10 (4) mononuclear cells ; P =. 43) or simvastatin 80 mg (pre - vs posttreatment, 6. 1 [2. 9 ; 15. 2] vs 4. 0 [1. 4 ; 10. 7] EPCs/10 (4) mononuclear cells ; P =. 5), and there were no differences between the groups on treatment effects (P =. 9).